Gran Tierra Energy Inc. Announces 2026 Guidance and Operations Update Targeting Free Cash Flow of $60 to $80 Million in the 2026 Base CaseEcuador Program Transition From Exploration to Appraisal & Development Colombia Program Focused on Maximizing Free Cash Flow Development Program Focused on Quick Payouts and Capital Efficient Projects2026 Capital Program Fulfills Commitments Over the Suroriente Block Reported Current Company Production of 48,000 to 49,000 BOEPD CALGARY, Alberta, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GT...
A director at Salesforce Inc sold 33 shares at 0.000USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...
Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer Positive results of ERNA-101 in ovarian cancer models demonstrated promising survival benefit and immune activation, underscoring the potential for broad oncology applications, including hematologic malignancies CAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the presentat...
Moody's Ratings (Moody's) has placed Gran Tierra Energy Inc.'s ("Gran Tierra") Corporate Family Rating and senior secured notes B2 ratings under review for downgrade. Previously, the outlook was positive. RATINGS RATIONALE / FACTORS THAT COULD LEAD TO AN UPGRADE OR DOWNGRADE OF THE RATINGS The r...
Victoria’s Secret & Co. Reports Third Quarter 2025 Results and Raises Full Year Guidance Delivered Net Sales of $1.472 Billion, a 9% Increase Versus Prior Year, Exceeding ExpectationsOperating Results and Earnings Exceed ExpectationsRaises Fiscal Year 2025 Net Sales, Operating Income and Earnings Guidance REYNOLDSBURG, Ohio, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Victoria’s Secret & Co. (“VS&Co” or the “Company”) (NYSE: VSCO) today reported financial results for the third quarter ended November 1, 2025. Hillary Super, VS&Co Chief Executive Officer, said, “We delivered a standout third quarte...
A Closer Look at FY3Q26 (October) ResultsRevenueTotal revenue of $10.26 billion (up 9% y/y and 8% y/y in CC) was in line with both the company’s guidance range for revenue between $10.24 billion and $10.29 billion and the Street’s $10.27 billion estimate driven by Agentforce, Data 360, and Agentfor
Ernexa Therapeutics Announces Oral Presentation at the 67th American Society of Hematology (ASH) Annual Meeting CAMBRIDGE, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that data from its novel cell therapy platform will be shared in an oral presentation at the , being held December 6-9, 2025 in Orlando, FL. “Being selected to give an oral presentation at ASH is a tremendous honor and a major milestone,” said Sanjeev Luther, President & CEO of Ern...
Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG Appointment reinforces clinical and translational depth as Ernexa advances its best-in-class iMSC cell therapy platform into first-in-human trials CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the appointment of Dr. Ira S. Winer, M.D., Ph.D., FACOG, to its . Dr. Winer is a nationally recogni...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.